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Abstract 
 
The case study described in this paper aims to illustrate how qualitative 
and quantitative system dynamics modelling and multicriteria analysis can 
be used in an integrated way to enhance the process of performance 
measurement and management in the radiotherapy department of a major 
UK cancer treatment centre. The complexity of the radiotherapy process 
and its significance for patients present particular challenges for 
performance measurement and management. The paper discusses the 
benefits arising and the practical difficulties faced in the study.  
 
 
Keywords: performance measurement; health services; multiple criteria 
analysis; system dynamics. 
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Introduction 
 
Formal or informal performance measurement is common practice in most organisations 
and it is well established that this plays a critical role in signalling the level of success in 
achieving objectives and identifying where improvement efforts are required. Several 
performance measurement frameworks have been developed to address these needs; 
among these the balanced scorecard (Kaplan and Norton, 1992), the performance 
pyramid (Lynch and Cross, 1991), the results and determinants framework (Fitzgerald et 
al., 1991), and more recently, the performance prism (Neely, Adams and Kennerley, 
2002), are better known examples.  
An evaluative review of the literature highlights two key issues that need to be 
properly addressed if performance measurement systems are to provide a stronger basis 
from which to manage effectively for improvement. Firstly, an effective design process 
is required to help identify an appropriate set of performance measures and develop a 
system which: promotes understanding about the dynamic relationships and trade-offs 
between performance measures; facilitates synthesis of the performance information into 
a meaningful and manageable form; and enables decision makers to understand the 
reasons why a particular level of performance is observed. Secondly, in order to promote 
continuous performance improvement through better decision-making, the different 
stages of the performance measurement and management process must become part of a 
continuous cycle. Unless performance assessment is viewed as an integral part of a 
process of organisational learning, enabling decision makers to change the way they 
think and act and to make a more effective use of the available information, its ultimate 
impact will be limited. 
Although it has been recognised that there are a number of Operational Research/ 
Management  Science (OR/MS) methods which can potentially enhance the processes of 
performance measurement and management (e.g., Dyson, 2000; Smith and Goddard, 
2002; Ackermann et al., 2005), published accounts of their use are rare. For example, 
Shutler and Storbeck (2002) comment on the difficulty in filling a complete special issue 
of an OR journal on the topic of performance management due to the lack of papers. 
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In a previous paper (Santos, Belton and Howick, 2002) the authors proposed a 
theoretical framework incorporating the integrated use of multicriteria decision analysis 
(MCDA) and system dynamics (SD) to assist performance measurement and 
management. The testing of the proposed framework in an organisational context, with 
the longer-term aim of refining the methodology, was identified there as an objective for 
further research.  
In this paper we describe a case study, conducted in the radiotherapy department 
of the Beatson Oncology Centre, one of the major UK cancer treatment centres, which 
was part of a programme of action research to meet the above objective. The key 
research objectives of the study were to explore the value of the integrated use of SD 
and MCDA in providing support for performance measurement and management, and 
the nature of the practical difficulties and challenges that arise in doing so. Further to 
this, the paper contributes to the growing literature on the use of OR/MS in healthcare 
management (see, for example, the recent special issue of JORS edited by Davies and 
Bensley, 2005 and the forthcoming issue of the European Journal of Operational 
Research edited by Brailsford and Harper, editorial available online, October 2006) and 
in particular to that on the use of SD (e.g., Dangerfield and Roberts, 1999; 
Wolstenholme, 1999; Lane, Monefeldt and Rosenhead, 2000; Brailsford et al., 2005) 
and MCDA (e.g., Min, Mitra and Oswald, 1997; Bohanec, Zupan and Rajkovic, 2000; 
Bots and Hulshof, 2000; Mosmans, Praet and Dumont, 2002; Dolan, 2005). 
We begin by outlining the performance measurement and management process 
and the potential to enhance this through the use of SD and MCDA.  A brief description 
of the context of the case study follows. This is expanded as we describe in detail the 
development of a performance measurement system in accordance with the proposed 
framework. We conclude with a discussion of the impacts and challenges of the 
intervention.  
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The performance measurement and management process 
 
At the most general level, a robust framework for performance measurement and 
management should revolve around a four-stage process, as illustrated in Figure 1, 
which assists the:  
• design of the measurement system. The design process enables decision makers to 
develop an integrated set of performance measures, to set targets and to define the 
procedures for periodic data gathering;  
• measurement of key metrics. The measurement process enables organisations to 
learn how they have performed (i.e., what happened). However to fully understand 
performance results, they must be properly analysed;  
• analysis of metric results. The analysis process enables decision makers to 
understand why the organisation is performing as it is and to identify the need for 
corrective actions. An informed understanding of performance is an essential basis 
for design of effective action (to improve poor performance or to maintain and 
reinforce good performance); 
• and improvement of operations. Through further analysis, the improvement process 
enables decision makers to explore the likely effects of alternative corrective actions 
on the organisation’s performance, leading to better-informed decisions.  
 
 
 
Figure 1 – The performance management process 
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Once measurement results have been collected, analysed, communicated 
(internally and externally), and used for the development of corrective action, effective 
performance management requires that the organisation’s strategy and measurement 
system be updated accordingly to ensure that it continues to meet changing needs. Then 
the cycle begins again. Successful accomplishment of these four main tasks represents 
the foundation of good performance management. As described in Santos, Belton and 
Howick (2002), and indicated in Figure 1, we believe that SD and MCDA can make a 
significant contribution to the successful accomplishment of these four tasks and the 
closing of the performance measurement loop.  
Both SD (see, for example, Forrester, 1961 and Sterman, 2000) and MCDA  
(see, Belton and Stewart, 2002, for an overview of the field and Keeney and Raiffa, 
1976, or von Winterfeldt and Edwards, 1986, for more detailed descriptions of the multi-
attribute value analysis approach used in this study) have been the focus of intensive 
research for more than three decades, and considerable developments have been seen in 
theory and practice. Each has individually proved their potential to inform and support 
decision-making. The strength of SD is in capturing the dynamics of a system, and that 
of MCDA is in providing a framework for exploring multiple, often conflicting, goals. 
Although the dynamic and multi-criteria nature of any system of performance measures 
is generally acknowledged (e.g., Mapes, New and Szwejczewski, 1997; Tatikonda and 
Tatikonda, 1998; Bititci, Turner and Begemann, 2000; Da Silveira and Slack, 2001), 
there is little published on the use of either SD or MCDA for performance measurement 
and management. Exceptions are: Rangone (1996), Bititci, Suwignjo and Carrie (2001), 
and Clinton, Webber and Hassell (2002), who use or mention the use of the Analytic 
Hierarchy Process approach to MCDA; and Davis and O’Donnell (1997), Boland and 
Fowler (2000), and Akkermans and van Oorschot (2005), who use or mention the use of 
SD. To the best of our knowledge, there is no published exploration of the synergy to be 
derived from the integrated use of MCDA and SD as part of a performance measurement 
system. Indeed, reported accounts of the formal integration of MCDA and SD are 
relatively few and they are in a different context (e.g., Hammond et al., 1977, 1978; 
Mumpower, Veirs and Hammond, 1979; Gardiner and Ford, 1980; Dennis et al., 1983; 
Gruver, Ford and Gardiner, 1984; Reagan-Cirincione, et al., 1991; Andersen and 
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Rohrbaugh, 1992;  Brans et al., 1998; Kunsch, Springael and Brans, 1999; Rosas- 
Flunger, 2000; Kunsch, Chevalier and Brans, 2001; Schmidt and Gary, 2002; Springael, 
Kunsch and Brans, 2002; Chevalier, Kunsch and Brans, 2004; Olson, Dimitrova-
Davidova and Stoykov, 2005; Rabelo et al., 2005).  
 
 
Performance Management in a Radiotherapy Department 
 
Radiotherapy along with surgery is a major modality in the management of cancer and it 
is used as a primary treatment for many types of cancer. Most commonly, radiotherapy 
is administered from an external source, usually a linear accelerator (also known as 
LinAc), with the beam being concentrated on the tumour. At the simplest level, 
radiotherapy may be part of a programme of treatments intended to cure the patient’s 
tumour (radical radiotherapy), or it may be used to relieve symptoms of advanced 
disease (palliative radiotherapy). Whatever the intent, the use of radiation for the 
treatment of cancer is a complex, multi-step process, involving trained personnel who 
carry out a variety of interrelated activities.  
Whilst measurement and improvement of performance are major concerns of 
most radiotherapy departments, these are particularly challenging managerial tasks due 
primarily to the complex nature of cancer treatment and to the multiple and sometimes 
conflicting needs and demands on the several stakeholders involved, including patients, 
health care professionals, administrative and managerial staff, as well as central 
Government. The wide range of views held by these stakeholders regarding what 
represents good performance demands a balanced set of measures to assess that 
performance and to ensure that trade-offs between objectives are explicitly considered.  
The case study discussed here was conducted over a period of several months in 
the Beatson Oncology Centre in Glasgow, one of the United Kingdom’s largest centres 
for non-surgical cancer treatment. It was organised in two main stages: the first stage 
was concerned with analysing the existing performance measurement practices within 
the department; and the second stage aimed to explore the use of SD and MCDA as 
means to add value to these practices. The study involved repeated visits to the 
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department, to interview clinical and managerial staff, including the superintendent 
radiographer (who has overall responsibility for radiographic staff and their standards of 
care), extensive study of relevant documentation, and collection and analysis of 
numerical data. 
Findings from the first stage revealed that although tools and processes to 
measure organisational performance existed within the radiotherapy department, there 
was still considerable scope for improvement. In particular, the department could benefit 
from the development of a structured, systemic performance measurement framework 
based on a comprehensive and balanced set of performance measures. 
The second stage of the study involved a series of meetings with key personnel 
responsible for the service under review, with the aim of: (1) developing a ‘new’ 
performance measurement system incorporating the integrated use of SD and MCDA, 
and (2) assessing the extent to which the ‘new’ system could overcome some of the 
shortfalls of the existing measurement practices as identified in the first stage of the case 
study research. 
In the following three sections we discuss the process used to design the ‘new’ 
system to permit analysis of the levels of performance of the department, and 
exploration of possible improvement strategies. In the final section, we discuss the 
ability of this process to add value to the existing performance measurement practices 
within the department.  
 
 
Designing a ‘New’ Performance Measurement System 
 
Identifying the key performance areas 
 
It is often suggested that the design of a performance measurement system should start 
with a clear identification of the organisation’s mission and strategic objectives (e.g., 
Wisner and Fawcett, 1991) or with the identification of the stakeholders’ wants and 
needs (e.g., Neely, Adams and Crowe, 2001). Assisted by the information gathered 
during the first stage of the case study, we began the second stage by trying to describe 
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what an ideal radiotherapy facility would look like from the point of view of the main 
stakeholders and what the main objectives of such as system would be.   
A system of ideal radiotherapy cancer care would, among other things, ensure 
that: (1) all clinically eligible cancer patients within a facility’s catchment area have 
timely access to radiotherapy services; (2) the care provided is clinically effective, in 
line with agreed standards, and is delivered with the minimum disruption to the patients’ 
lives; (3) equipment is utilised at maximum efficiency and staff workload levels allow 
the delivery of a safe and high quality service; and (4) there are enough resources 
available to ensure the provision of an effective, efficient and accessible radiotherapy 
service. These four main themes – Fair Access to Services, Clinical Effectiveness and 
Outcomes, Efficiency, and Capacity and Capability – strongly reflect those found in the 
Performance Assessment Framework (NHS Executive, 1999), and were identified by the 
team tasked with developing the measurement system as key dimensions of performance 
on which to concentrate. 
It is important to note that although the identification of these dimensions of 
performance constituted an important step in the overall assessment process, they did not 
immediately present a workable framework for detailed evaluation of the performance of 
the radiotherapy department. To thoroughly assess, for example, if a radiotherapy 
department is providing clinically effective health care or if it is ensuring that people’s 
ability to obtain health care is related to their needs, these dimensions should be broken 
down further. In general, these dimensions should be decomposed to a level where they 
can be easily assessed. That is, they should be ultimately decomposed into performance 
measures. 
 
Understanding the cause and effect relationships between areas of performance 
 
Having identified the four main objectives and key dimensions of performance on which 
to concentrate, the system design process then focused on identifying the measures that 
best capture achievement of these objectives. At this stage, particular emphasis was 
placed on understanding and describing cause and effect relationships. A useful step in 
this direction and, ultimately, in identifying an appropriate set of measures was the use 
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of a simple causal loop diagram (CLD) to capture the key feedback structure of the 
radiotherapy treatment dynamics within the department. Causal loop diagrams are maps 
showing the causal links among a set of variables operating in a system, with arrows 
from a cause to an effect. CLDs are developed following well-established guidelines 
(e.g., Coyle, 1996, Chapter 2; Sterman, 2000, Chapter 5) and despite their limitations 
(e.g. Richardson 1986, 1997) they have proved highly effective in representing the 
feedback structure of systems. Using this tool, several feedback loops, and interlinkages 
between different loops, were identified, mapped, and subsequently integrated into a 
single diagram (Figure 2). This was developed in close interaction with the 
superintendent radiographer and was based on the information collected during several 
interviews. The purpose was to obtain a view of the components of the system and the 
dynamic interactions between them, leading to insights about the key performance 
drivers.  
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Figure 2 – A Simplified Causal Loop Diagram for the Radiotherapy Treatment 
Dynamics 
 
 
+
- 
+ 
+ 
+ 
- 
- 
Loop 1 
Loop 2 
Loop 3 
Loop 4 
Loop 5 
Loop 6 
Loop 7 
 11
Figure 2 is a simplified representation of the real system. Nevertheless, this 
simple model enables us to illustrate the insights that can be gained from its use. The 
CLD contains several feedback loops which reflect the interplay of the structural and 
behavioural forces in the system. Loop 1 and 2, for example, illustrate the key feedback 
structure of average waiting time for radiotherapy treatment. Loop 1 represents the 
demand side: other things being equal higher demand for radiotherapy leads to an 
increase in the number of patients on the waiting list, hence to longer average waiting 
times, but, in general, longer average waiting times lead to lower demand. As indicated 
in the diagram by the double bar symbol //, there is a delay between the moment when 
information about waiting times becomes available, and when it affects decisions about 
the use of radiotherapy. That is, it takes time for cancer patients and especially their 
surgeons and/or clinical oncologists to perceive changes in the radiotherapy waiting time 
and adjust their prescribing behaviour by looking for alternative forms of treatment (e.g., 
chemotherapy and/or surgery). It is important to note that in addition to new patients, the 
waiting list is also fed by patients who return for further treatment. As indicated, the 
recurrence rates are also, to some extent, influenced by the waiting times. Delays in 
treatment may allow progression of the tumour resulting in a worse outcome and, 
therefore, increasing the risk of recurrences.  
Thus, the provision of timely treatment for cancer patients is critical as it 
increases the opportunity for optimal outcomes, including improved rates of cure, longer 
survival, and better quality of life. Because cancer cells continue to grow and divide 
much faster than normal cells while a patient waits for treatment, local control of the 
cancer may become compromised, with increased toxicity of treatment or lower rates of 
organ preservation if patients face prolonged waits. 
The wait for treatment is also psychologically damaging for patients wishing to 
start therapy as quickly as possible and is therefore a major source of dissatisfaction. 
Loop 2 is the managerial loop for regulating the department’s capacity and it 
represents the supply side: increased waiting times result, after some delay, in more 
resources being allocated to radiotherapy treatment which, through an increase in 
admissions, leads ultimately to shorter average waiting times. As illustrated, the waiting 
list is reduced and the number of patients in treatment is increased, by an increase in 
 12
admission rate. Although high admission rates may lead to desirable consequences (e.g., 
lower waiting times), they may also lead to undesirable ones. The higher the admission 
rates and, consequently, the number of patients in treatment, the higher the staff 
workload. It is well known that unacceptably high workload levels limit the time 
available for staff development and, as a result, are damaging for morale (see Loop 3 in 
Figure 2).  
The number of patients in treatment governs the extent to which the department’s 
capacity is utilised. When that utilisation falls and there are vacancies, patients are 
admitted from the waiting list until all the available places are filled. It is also important 
to mention that utilisation levels must allow for maintenance downtime and for the 
treatment of urgent and, therefore, unscheduled patients. The patients in treatment are, in 
turn, reduced by the discharge rate. The number of patients discharged per month 
depends on the average duration of treatment. The overall radiation dose is delivered as 
a number of fractions, for example, a patient’s course of treatment might consist of 30 
fractions delivered on a daily basis (Monday to Friday) over a period of 6 weeks. The 
higher the number of fractions (i.e. the number of visits for radiotherapy) and the 
duration of gaps per course of treatment, the longer the treatments will last. On average, 
the discharge rate is simply a delayed version of the admission rate, the duration of the 
delay being the average duration of the radiotherapy treatment. Furthermore, and as 
previously noted, after a delay a proportion of those discharged will return for further 
treatment. Both the waiting times and the gaps in treatment cause the patient condition to 
deteriorate, adversely affecting the local control of the tumour, and therefore playing a 
critical role in the recurrence rates. Up to a point, a decrease in the local cancer control 
rate will increase the fraction of patients recurring and decrease the delay before they do 
so. Beyond that point, a decrease in the local cancer control rate will have an opposite 
effect, as patients become too ill to receive radiotherapy.  
It is also important to note that overall cure rates are primarily determined by 
tumour stage at clinical presentation. As illustrated in the CLD, the local cancer control 
rates, which are an important measure of the clinical effectiveness of radiotherapy 
treatment, are affected by endogenous factors such as waiting times and gaps in 
treatment. However, they are also determined by exogenous factors such as the cancer 
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stage and grade or aggressiveness at the time the patient is referred to the radiotherapy 
department, factors over which the department has no control. If cancer is advanced at 
presentation or recurs after initial therapy, the outcome is often poor. 
 
Selecting the key performance measures 
 
Based on the CLD and on the increased understanding that emerged from its 
development, a small set of performance measures was derived and structured in a 
performance measures tree as shown in Figure 3. These measures, some of which were 
later broken down into more specific performance indicators, formed the basis of the 
performance measurement system. It is important to mention that this set was not 
intended to be comprehensive in covering all aspects of the department’s activities but to 
throw light on some particularly important issues for its effective management. For 
example, while several staff groups are necessary to deliver radiotherapy, including 
consultant clinical oncologists, physicists, electronic technicians and therapy 
radiographers, it was decided to use the number of clinical oncologists and therapy 
radiographers as a proxy for the staffing levels. This decision was taken for 
simplification purposes and data unavailability for other types of staff. However, when 
carrying out an exhaustive performance assessment exercise, we recommend the use of 
data regarding the number of all types of professionals. It is also important to mention 
that the measures in Figure 3 were chosen because they support the goals and strategies 
of the department. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 – Performance Measures Tree 
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The selection of this set of measures was significantly influenced by the key 
objective, which was to design a performance measurement system that would not only 
assess how the radiotherapy department was performing but also, and most importantly, 
would provide insights regarding the main causes for the performance observed and also 
insights about future performance. 
The performance measure ‘unscheduled interruptions (gaps) in treatment’ is a 
good example of one that meets these objectives. Firstly, as revealed by the CLD and 
associated mapping process, it provides valuable information regarding the actual 
performance of the department. Monitoring gaps in treatment gives, for example, an 
indication of the efficiency in the use of resources. The causes for unscheduled treatment 
interruptions can be department-related, but may also be precipitated by deterioration in 
the patient’s condition. Nevertheless, a poor performance in this measure may indicate 
excessive equipment downtime, caused either by a deficient planning of machine 
servicing or by frequent breakdowns in machines.  
Secondly, it helps to explain the level of performance achieved by other 
measures. Enforced and unexpected breaks in treatment are psychologically damaging 
for patients and a major source of dissatisfaction. Therefore, a poor performance in this 
measure may help in explaining patient satisfaction levels. Similarly, gaps in treatment 
may also be a major source of delays for patients awaiting treatment. When gaps in 
treatment occur, and no allowance has been made for compensation during the 
prescribed treatment period, the missed fractions are usually given at the end of the 
period, which means that the treatment will take longer than planned and, consequently, 
it will take longer for new vacancies to become available. 
Finally, it has a predictive power as it provides useful insights regarding future 
performance and its likely implications for the department. It is well known that 
unscheduled and uncompensated interruptions in treatment have a detrimental effect on 
the local control of some cancers, significantly reducing the chances of achieving a cure. 
In particular, these interruptions impact significantly on the probability of cancer 
recurrence and on patients’ survival. Therefore, if the value of the measure ‘gaps in 
treatment’ is very poor at a particular point in time, it is very likely that the future 
performance of measures such as recurrence rates and survival rates will be poor.  
 15
A similar rationale was used to select the other performance measures. As 
mentioned previously, it is a critical objective of any radiotherapy facility to provide a 
clinically effective treatment to patients. Loco-regional control rates are a key outcome 
indicator of the underlying effectiveness of treatment and, therefore, they should be 
closely monitored. Furthermore, they are an important leading performance measure or 
performance driver of other outcome measures, including survival, quality of life, and 
recurrences. Having decided to measure the local cancer control rate, the next stage was 
to use the CLD to analyse what are the main factors under the control of the department 
that impact on this performance measure. As Figure 2 illustrates, both the waiting times 
and the unscheduled gaps in treatment have a detrimental influence on the local cancer 
control rate, and therefore, should be monitored. In addition, Figure 2 shows that both 
measures are a major source of patients’ dissatisfaction, which is another key measure to 
consider. An important question then arose: how can the department control the waiting 
times and the gaps in treatments? As we discuss below, an effective planning of the 
machines’ maintenance may help to reduce the gaps, and in this way, also reduce the 
waiting times. The problem of waiting time defies, however, a quick and simple answer 
because of the complexity of factors that might influence it. These may be short-term 
difficulties, such as machine breakdowns, temporary staff shortages, or long-term 
factors, such as an imbalance of patients and resources. Therefore, it is important that the 
measurement system includes measures that capture these factors, either directly or 
indirectly. In particular, measures should be selected to indicate if the department has 
enough resources available to provide an efficient, effective and accessible radiotherapy 
service. Through this process, a set of performance measures was identified (please refer 
to Figure 3).  
As can be seen from Figure 3, the measures selected relate to structure, processes 
and outcomes, over which the radiotherapy department has some degree of control and 
which provide a sufficiently balanced assessment across the four key areas of 
performance considered.  
Having identified the performance dimensions and measures considered to be 
relevant in evaluating the department’s performance, the next step was to set targets for 
each of these measures and to find out how well the department was achieving them.  
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Measuring the Performance of the Department 
 
The procedure we used to evaluate the radiotherapy department against each individual 
measure, and to arrive at an indicator of overall performance, made use of a hierarchical, 
weighted additive value function and was supported by the multicriteria decision support 
system V⋅I⋅S⋅A (Visual Interactive Sensitivity Analysis), as proposed elsewhere (Santos, 
Belton and Howick, 2002). Figure 4 illustrates elements of the model used to evaluate 
the annual performance of the department in the year 2002/03.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – A Section of the V⋅I⋅S⋅A Model 
 
The measures discussed earlier are grouped under the four dimensions indicated to give 
the performance tree shown. The raw data in the Alternative Window (Figure 4-A) 
indicates the value of the performance measures on the natural scales for the year 
2002/03. For example, we can see that from April 2002 to March 2003, the department 
delivered an average of 2,270 courses of radiotherapy per million population, and that 
the average waiting time from deciding to administer a course of radiotherapy to starting 
treatment was 36 days for patients awaiting radical treatment, and 11 days for patients 
awaiting palliative treatment.  
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Although these figures convey useful information, they are of limited value by 
themselves since they may be difficult to interpret in the absence of reference targets. 
For example, while a waiting time of 36 days for radical and, therefore, potentially 
curative treatment may be considered an acceptable performance in a cancer centre with 
limited radiotherapy resources, this is not likely to be the case in a cancer centre with no 
capacity shortages. It was therefore important to establish targets for each performance 
measure, and to analyse how well the department performed against these targets. 
Although it was desirable to define these targets based on a deep knowledge of the key 
stakeholders value systems, due to time restrictions on the part of some of these 
stakeholders (e.g., health care professionals and managerial staff), an alternative but also 
theoretically acceptable approach was adopted. The targets for each performance 
measure were defined by reference either to recommendations issued by prominent 
organisations in the area of radiotherapy treatment (e.g., Royal College of Radiologists) 
or to ‘industry benchmarks’ drawn from the results of surveys commissioned by the 
Department of Health regarding radiotherapy services in England and Wales (e.g., 
Department of Health, 1999; 2001; 2002). Based on this information, two reference 
points were defined for each performance measure, corresponding to the worst and best 
performance that could realistically occur. These levels were assigned values of 0 and 
100 respectively. Once these reference points were determined, a value function was 
defined to assess intermediate scores using percentiles. Although this does not define a 
smooth value function, as would be expected, it was felt appropriate to fit the empirical 
data available. Figure 4-B shows a possible value function for the performance measure 
‘courses of radiotherapy per million population’, and how the performances on the 
natural scale are converted, within the V⋅I⋅S⋅A model, into value scores on a 0 to 100 
scale. In this case, a score above 50 means that the department performed better than 
half of its peers, while scores below 50 mean that the department performed worse than 
half of them. 
Having defined the value functions for each performance measure, it was 
relatively straightforward to evaluate the levels of performance of the department against 
each of the bottom-level performance measures in the tree. Figure 4-C shows, for 
example, the performance of the department against the measures related to the 
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dimension ‘fair access to services’. Each performance measure is represented by a 
vertical bar and the performance profile of the radiotherapy department is shown by a 
coloured line crossing these bars at the appropriate point. It is easily seen if the 
department has a good (or poor) all-round performance, or combines significant 
strengths in some measures with weaknesses in others. In this particular example, it can 
be seen that the department is performing comparatively better on the measure 
‘palliative waiting time’ than in the measures ‘courses of radiotherapy per million 
population’ and ‘radical waiting time’. However, an important question remains. 
Overall, is the radiotherapy department providing a fair access to its services? By 
themselves, the levels of performance achieved do not provide conclusive evidence of 
poor or good performance, unless they are analysed together with the department 
priorities and ‘values’.  
Due to the limited resources available, it is important for health care 
organisations to define priorities. For example, is it a priority of a particular radiotherapy 
department to provide a relatively quicker service to palliative patients or to radical 
patients? Is it to broaden the access to radiotherapy even if this means that patients will 
have to wait longer, or is it to provide treatment to fewer patients but ensuring that the 
treatment will be provided quickly? Considering the performance levels represented in 
Figure 4, it is easy to conclude that the overall performance of the department regarding 
the fairness of access to its services will be higher, the higher the weight attributed to the 
performance measure ‘palliative waiting time’, and the lower the weight given to the 
performance measure ‘radical waiting time’.  
When the scores of each performance measure within a performance dimension 
are combined with the respective weights, we obtain the overall performance score of 
the department in this dimension. Figure 4-D shows the aggregate score for the 
dimension ‘fair access to services’ if the relative importance of each of the measures 
contributing to this dimension is captured by the weights shown. The aggregate scores 
on each of the four key dimensions can be combined with appropriate weights to obtain 
an overall indicator of the performance of the department. This overall score can assist 
the management team to track performance over time and to see if particular changes 
made in the operations of the department have improved or hindered the overall 
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performance, whilst bearing in mind that the real learning comes from understanding 
why this has resulted from the actions taken and the stated priorities.  
The weights reflect acceptable trade-offs among measures and should be elicited 
from stakeholders in accordance with their preferences and priorities for each 
performance measure, based on well-established axioms of decision-making. There are 
many questioning procedures which seek to elicit this information (see, for example, 
Kenney and Raiffa, 1976). However, in this study we did not attempt to elicit a 
definitive set of weight values; instead the emphasis was on using the model to illustrate 
the possibility to derive aggregate measures and explore the consequences of different 
priorities.  
It is well known that achieving effective use of performance information calls for 
proper presentation to and discussion with users. To these ends we tested the use of a 
‘traffic lights’ colour coding, which is familiar to some health care organisations in the 
UK (see Department of Health, 2000), as illustrated in Figure 5. This highlights areas of 
strength in the organisation (marked green) and areas for improvement (marked yellow 
or red), thus supporting planning for a process of continuous improvement. The colours 
assigned to each performance measure were based on the V⋅I⋅S⋅A scores. 
It is important to emphasise that Figure 5 was used exclusively for illustrative 
purposes, as the lack of readily available data for some of the performance measures 
(e.g., local cancer control rates and patient satisfaction) prevented us from undertaking a 
definitive evaluation of the department at the time the case study was conducted. 
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Figure 5 – Performance Results Using a ‘Traffic Lights’ System 
 
 
Analysing the Results and Testing Improvement Alternatives 
 
Having completed the organisational diagnosis, the next stage was to seek insights into 
the reasons for the levels of performance achieved and to explore possible responses. As 
discussed earlier, the Multi-Attribute Value Function (MAVF) approach, allowed us to 
look at individual performance measures and to synthesise that information to indicate 
how the radiotherapy department performed on each of the key dimensions and overall. 
However, whilst this information is important for monitoring the performance of the 
department and to indicate where improvement is required, it is of limited value if it is 
seen as an end in itself. As previously emphasised, to be effective, a performance 
measurement and management system has to support decision-making. It must inform 
decision makers about the reasons for poor (or good) performance, and provide insights 
about possible actions to achieve desired changes.  
 
Therapy
Radiographers
Clinical 
Oncologists
LinAcs per 
Million 
Population
Average 
Duration 
of Gaps
Patients per
Oncologist
Fractions 
per LinAc 
per Hour
OVERALL 
PERFORMANCE
Waiting Time 
for Radical
Treatment
Waiting Time 
for Palliative
Treatment 
Courses per 
Million
Population
Patient 
Satisfaction
Local Cancer 
Control Rates
Fair Access
to Services
Capacity &
Capability
Clinical 
Effectiveness 
& Outcomes
Efficiency
 
 
                                                                                                         Key:  
(green) 
(yellow) 
(red) 
Score ≥ 50: Good performance 
Score < 50 and ≥ 40:Satisfactory performance 
Score < 40: Unsatisfactory performance 
 
 21
However, identifying the causes of problems and developing appropriate 
solutions are frequently difficult processes for the unaided decision maker. In order to 
try to understand the reasons for the levels of performance observed, we adopted a 
systems perspective. In particular, the analysis of the performance results focused on the 
underlying causal structure of the radiotherapy system discussed earlier (Figure 2). We 
use the performance measure ‘radical waiting time’ to illustrate this thinking. 
As seen in Figure 4-C, the level of performance achieved in the measure ‘radical 
waiting time’ was unsatisfactory, resulting in a red traffic light indicating a substantially 
unmet target in Figure 5. With the objective of exploring possible causes of the observed 
level of performance, we started by analysing its pattern of behaviour over the previous 
four years. Considering that we adopted a systemic perspective in the development of 
the measurement system, we were interested in analysing patterns of change alongside 
information snapshots. 
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Figure 6 – Pattern of Behaviour of Radical Waiting Times 
 
This revealed that the radical waiting times presented an oscillatory mode of 
behaviour over these previous four years (see Figure 6), suggesting that it has been 
generated by a negative feedback loop with delay, in accordance with loop 2 in the CLD. 
As previously mentioned, loop 2 is the managerial loop regulating the department’s 
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capacity. Long waiting times result, after some delay, in more resources being allocated 
to the radiotherapy department which leads ultimately to shorter average waiting times. 
Inspection of the capacity of the department over an identical time period (measured by 
the number of hours worked per month and the number of LinAcs available) revealed 
that the capacity may have played an important role in the behaviour of the waiting time 
performance for radical treatments.  
It is indeed important to note that the MAVF analysis revealed that the levels of 
performance in two of the three capacity measures, is rather unsatisfactory. This is 
confirmed by the red indicators assigned to the measures ‘LinAcs per million 
population’ and ‘therapy radiographers per million population’ (Figures 5 and 6), which 
show that the capacity available in the department is below the minimum capacity 
judged to be necessary to provide a fair access to services. Coupled with the information 
about the links between measures (shown in Figure 2 and again in Figure 6) this 
suggested that capacity shortages may have played a key role in the level of the 
performance measure ‘radical waiting time’. This observation was in accordance with 
the belief of the management team regarding the fact that the unsatisfactory delays for 
radical treatments were mostly related with the capacity of the department, which was 
not believed to be enough to cope with the demand for the radiotherapy services. It was 
recognised that the department was understaffed, in part due to a national shortage of 
some staff groups (including radiographers and physicists) and ill-equipped due to 
underfunding. Nevertheless, there was a planned expansion of human resources and 
equipment. 
However, and most importantly, the mapping of the CLD highlighted that many 
other factors in addition to available capacity influence the time that patients have to 
wait and should not be neglected in the analysis. Consideration of these factors, which 
was assisted by the CLD, led to valuable conclusions. Firstly, it highlighted the need to 
monitor, and if possible reduce, the equipment downtime. LinAc downtime, due to 
equipment breakdowns or regular servicing, reduces the capacity of the department and, 
therefore, negatively affects waiting times. Secondly, it highlighted that  ‘changes’ in the 
average duration of treatment, due to increases in gaps in treatment and to changes in the 
average number of fractions prescribed per course of treatment, are likely to have played 
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a critical role in the behaviour of the waiting times. While the average duration of 
treatment for palliative patients remained broadly constant during the period of analysis, 
this was not the case for the average duration of treatment for radical patients. The 
pattern of behaviour of this variable mimicked, in some extent, the pattern of behaviour 
of the variable ‘radical waiting times’. This was an interesting finding because it had not 
been anticipated by the management team. Furthermore, this issue is particularly 
interesting because fractionation is a controversial issue. The effect of different 
fractionation policies on the prognosis of patients, and on their experience of side 
effects, remains unclear in most cases, and more research is needed to clarify this issue 
(Commission for Health Improvement, 2001). Considering that local fractionation 
policies do vary considerably between radiotherapy facilities, and they are often 
developed based on clinical traditions or working practices rather than in solid empirical 
evidence, it could be very valuable to explore the effect that changes in these policies 
would have in the waiting times for treatment. 
In order to analyse in greater detail the effect that these and other changes can 
have on the dynamics of the system, and to explore possible performance improvement 
actions, we developed a simple SD simulation model using PowerSim. Along with the 
explicit representation of the system’s internal structure, a user-friendly interface was 
built to allow us to analyse different system configurations and scenarios (see Figure 7). 
The output of a PowerSim simulation/scenario was used to define a new alternative in 
the V⋅I⋅S⋅A model (with the two softwares being linked via a spreadsheet). By 
introducing changes in some parameters and running the SD model we could observe the 
changes that occur over time in the variables of interest, and the consequences of these 
changes as reflected in the multicriteria performance measurement framework. Figure 7 
shows the investigation of a new scenario in which the average number of fractions per 
radical patient is reduced relative to the 2002/3 level. The impact on waiting times is 
seen in the displayed graph and the performance profile of the new scenario can be 
compared with the status quo in the V⋅I⋅S⋅A display. Considering that some of the 
performance measures are conflicting, it is likely that different actions will have 
different strengths and weaknesses. By cycling between the SD model and the MCDA 
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procedure, decision makers could enhance their understanding about these strengths and 
weaknesses, and make a better informed decision.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Portion of the Simulation and MCDA Model 
 
An important feature of the V⋅I⋅S⋅A software is that it allows interactive 
exploration of changes in inputs to the model, with the impacts being seen immediately 
in easy to interpret visual format. This sensitivity analysis can be used to explore the 
robustness of “conclusions” to priorities and values of different stakeholders, and when 
“disagreement” exists to highlight the rationale for this, thereby furthering discussion 
and understanding of others’ perspectives. The ability to “play” with the model is also a 
powerful means of building confidence in it and understanding of it. It is important to 
emphasise, however, that the possibility of running both the SD and MCDA approaches 
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in a single piece of software would make the implementation of the integrated approach 
easier as the user would have to manage only one interface. 
Despite the restrictions on data availability and the limited involvement by the 
key stakeholders in the process of building the SD model, the model developed was still 
considered to be a valuable tool by those most involved in developing the measurement 
system. It allowed us to explore and assess the potential to analyse the effect of different 
actions on the system’s performance measures over time. Furthermore, by linking the 
simulation model with the multicriteria decision support system the output could be 
easily synthesised and we could immediately evaluate the effect of these actions on each 
performance measure, aggregate dimension (such as “fair access to services”) and 
overall performance. Had we had the opportunity to obtain reliable estimates for all the 
variables, we could have explored, for example, which of the factors discussed 
previously most influenced the radical waiting times. Furthermore, we could also have 
used the simulation model to test and compare alternative actions to improve the 
system’s performance.  
In spite of the limitations of the simulation model, the process adopted showed 
that the use of SD and MCDA in this integrated form, can offer a powerful frame to 
analyse why a particular level of performance is observed and the ways by which 
changes in system’s performance may occur. 
 
 
 
Discussion and Conclusions 
 
This paper has discussed how SD and MCDA can enhance performance measurement 
and described the design of a performance measurement system for a radiotherapy 
department. This system aimed to address some of the limitations of the existing 
performance measurement practices, which included: absence of a structured 
measurement system able to evaluate the performance of the department on a regular 
basis; and an excessive focus of the performance assessment activities on a small 
number of individual measures at the expense of a more systemic and balanced view of 
performance.  
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The practical relevance of the use of SD and MCDA and their ability to enhance 
the practice of performance measurement and management within the radiotherapy 
department were assessed by using the information gained during the actual design of 
the performance measurement system, together with a follow-up workshop with the 
medical director, general manager and superintendent radiographer of the Beatson 
Oncology Centre. The case study has illustrated that the use of SD and MCDA, as part 
of an appropriate performance measurement system design process can bring new 
insights to inform and support the different stages of performance measurement and 
management within the department. In particular, the case study provided evidence that 
these approaches, used complementarily, permit:  
• the development of a holistic view of the system being assessed, captured as a 
qualitative causal map, and improved understanding about the dynamic 
interdependencies and trade-offs among performance measures, leading to;  
• the identification of an appropriate set of performance measures, which support;  
• a meaningful synthesis, using MCDA, of the available performance information 
into a few key indicators of performance and/or into a single indicator of overall 
performance;  
• increased understanding of the reasons why a particular level of performance is 
observed, and the ways by which changes in the organisation’s performance arise 
from the combined use of these two models;  
• rapid, but thorough, analysis and evaluation, in a risk free environment, of the 
effects of different actions on the department’s performance can be carried out 
using the quantitative SD and MCDA models, fostering learning through 
experimentation;  
• a proactive rather than reactive management of performance as a consequence of 
better understanding of the system and ability to predict the impact of changes. 
However, the procedure used for designing and measuring the performance of 
the department is not without its limitations. Firstly, it is inherently subjective in the 
choice of measures, in their weighting and potentially also in the scoring process.  
However, this subjectivity is made explicit and is informed both by analysis and by 
objective data. Furthermore, thorough sensitivity analysis is recommended to explore the 
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robustness of conclusions to changed assumptions and to shed light on the significance 
of subjective judgements. Secondly, the use of MAVT to develop an aggregate 
performance measure, although theoretically well founded is based on strong 
assumptions about the decision makers’ preferences (e.g. preference independence and a 
compensatory preference structure).  Formal checks should always be made and if the 
assumptions are not observed, a restructured or alternative form of model should be 
considered. Thirdly, while the use of MCDA allows decision makers to see easily, via 
the aggregative model, how their beliefs and preferences turn into a single or a few key 
indicators of overall performance, this simplicity occurs at the expense of detail. This 
loss of information is, however, easily compensated by drilling down into the hierarchy 
as needed, to see the performance of lower level measures and further by reference to 
the SD model. Fourthly, the use of a MCDA approach requires judgements that may be 
difficult to elicit from stakeholders. Finally, quantitative SD models can be very 
demanding in terms of modelling skills, time, resources and availability of data. It is, 
therefore, fundamental to assess whether the quantification of the qualitative models is 
going to add enough value to the process, over and above what has already been gained, 
to make it worthwhile. Overall, however, while limitations and implementation 
challenges exist, the case study evidence suggests that the benefits of the use of SD and 
MCDA can compensate its limitations. 
Finally, it is important to mention that the case study was not meant to be truly 
representative of all cancer treatment facilities, but instead was drawn to illustrate the 
applicability of and the insights emerging from the use of SD and MCDA to add value to 
the performance measurement and management process. However, although no two 
radiotherapy departments are exactly alike, the nature of the main problems they face is 
identical and, therefore, it is anticipated that similar conclusions would probably be 
obtained using other radiotherapy departments. 
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